From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1pkx.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:1pkx.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1pkx| PDB=1pkx | SCENE= }} | | {{STRUCTURE_1pkx| PDB=1pkx | SCENE= }} |
| | | | |
| - | '''Crystal Structure of human ATIC in complex with XMP'''
| + | ===Crystal Structure of human ATIC in complex with XMP=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Within de novo purine biosynthesis, the AICAR transformylase and IMP cyclohydrolase activities of the bifunctional enzyme ATIC convert the intermediate AICAR to the final product of the pathway, IMP. Identification of the AICAR transformylase active site and a proposed formyl transfer mechanism have already resulted from analysis of crystal structures of avian ATIC in complex with substrate and/or inhibitors. Herein, we focus on the IMPCH active site and the cyclohydrolase mechanism through comparison of crystal structures of XMP inhibitor complexes of human ATIC at 1.9 A resolution with the previously determined avian enzyme. This first human ATIC structure was also determined to ascertain whether any subtle structural differences, compared to the homologous avian enzyme, should be taken into account for structure-based inhibitor design. These structural comparisons, as well as comparative analyses with other IMP and XMP binding proteins, have enabled a catalytic mechanism to be formulated. The primary role of the IMPCH active site appears to be to induce a reconfiguration of the substrate FAICAR to a less energetically favorable, but more reactive, conformer. Backbone (Arg64 and Lys66) and side chain interactions (Thr67) in the IMPCH active site reorient the 4-carboxamide from the preferred conformer that binds to the AICAR Tfase active site to one that promotes intramolecular cyclization. Other backbone amides (Ile126 and Gly127) create an oxyanion hole that helps orient the formyl group for nucleophilic attack by the 4-carboxamide amine and then stabilize the anionic intermediate. Several other residues, including Lys66, Tyr104, Asp125, and Lys137', provide substrate specificity and likely enhance the catalytic rate through contributions to acid-base catalysis.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_14756553}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 14756553 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_14756553}} |
| | | | |
| | ==Disease== | | ==Disease== |
| Line 34: |
Line 38: |
| | [[Category: Purine biosynthesis]] | | [[Category: Purine biosynthesis]] |
| | [[Category: Xanthosine monophosphate]] | | [[Category: Xanthosine monophosphate]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 05:12:11 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:23:03 2008'' |
Revision as of 00:23, 29 July 2008
Template:STRUCTURE 1pkx
Crystal Structure of human ATIC in complex with XMP
Template:ABSTRACT PUBMED 14756553
Disease
Known disease associated with this structure: AICA-ribosiduria due to ATIC deficiency OMIM:[601731]
About this Structure
1PKX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor., Wolan DW, Cheong CG, Greasley SE, Wilson IA, Biochemistry. 2004 Feb 10;43(5):1171-83. PMID:14756553
Page seeded by OCA on Tue Jul 29 03:23:03 2008
